Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fitness RX vs Vita Bella

Fitness RX
Graded #50

Higher grade

vs+11.799999999999997
Vita Bella
Graded #233

Lower grade

The verdict

Fitness RX takes it — 76.7/100 to 64.9/100.

Fitness RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fitness RX (fitnessrx.com) is a GLP-1 weight-loss program that bundles medication with fitness and nutrition coaching across a three-phase plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFitness RX +36
80
44
Dose & formulationFitness RX +36
88
52
Clinical oversightVita Bella +8
83
91
Labs & monitoringVita Bella +15
62
77
FulfillmentVita Bella +10
73
83
Contract termsFitness RX +8
55
47
Fitness RX · left barVita Bella · right bar

The numbers

MetricFitness RXVita Bella
WeighScore76.7/10064.9/100
GradeCC
Scorecard rank#50#233
Semaglutide$119/mo (promotional rate, compounded)Not disclosed
Tirzepatide$119/mo (promotional rate, compounded)$159/mo (2.5 mg dose, plus a separate fee, compounded)
CoverageCoverage not published46 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Fitness RX

Graded #50 · C

Strengths

  • $119/mo all-in including medication, 1:1 physician consults, and unlimited messaging ($100-off-for-life intro promo)
  • Both compounded (injectable + sublingual semaglutide/tirzepatide) and brand GLP-1 (Wegovy, Zepbound)
  • Integrated fitness and nutrition/behavioral coaching (linked to the BodyFX brand)
  • Publishes Terms, Privacy, and data-privacy policies; links to LegitScript verification

Where it loses points

  • Promo-driven landing page; compounding pharmacy and legal entity not named
  • Tirzepatide and brand pricing may differ from the advertised $119/mo plan
  • LegitScript status links to a CAPTCHA-gated checker — not independently confirmed here
  • Exact drug and dose are shown only after the intake quiz
Vita Bella

Graded #233 · C

Strengths

  • Offers both compounded semaglutide (from $109/mo) and tirzepatide (from $159/mo) at member pricing, with supplies and a B-6 add-in included
  • Genuine LegitScript-certified website (seal #4395819) and a clearly disclosed legal entity, Vita Bella Health, LLC (Nevada)
  • Broad access: care published for 46 states plus Washington, D.C., and HSA cards are accepted
  • Fully remote telehealth with video provider consults and quarterly provider check-ins included in the membership
  • Medications dispensed by US FDA-inspected compounding pharmacies; ondansetron for nausea provided at no extra charge

Where it loses points

  • Advertised $109-$159 medication prices require a separate $129/mo membership plus a one-time $99 consult, pushing true cost to ~$238-288/mo
  • Three-month minimum commitment before it renews month-to-month; no refunds on medications and all sales are final
  • Compounding pharmacy partners are not named anywhere on the site — a transparency gap
  • Compounded semaglutide and tirzepatide are not FDA-approved; only the dispensing pharmacies are described as FDA-inspected
  • Disputes are subject to binding arbitration with a class-action waiver, governed by Nevada law (Las Vegas jurisdiction)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard